E-LIB Suche - Ergebnisse für: Rohatagi, Shashank ( author )

1

Mathematical modeling of cortisol circadian rhythm and cort..:

Department of Pharmaceutics, College of Pharmacy, University of Florida, Gainesville, FL 32610, USA ( host institution ) ; Rohatagi, Shashank ( author ) ; Bye, Alan ( author )..
European Journal of Pharmaceutical Sciences. , 1996

Link: https://doi.org/10.1016/..

2

A Double‐Blind, Placebo‐Controlled Study of the Efficacy an..:

Hampel Jr., Frank ; Gillen, Michael ; Rohatagi, Shashank S....
The Journal of Clinical Pharmacology. 42 (2002) 10 - p. 1097-1104 , 2002

Link: https://doi.org/10.1177/..

3

A population pharmacokinetic–pharmacodynamic model evaluati..:

Eudy‐Byrne, Rena ; Riggs, Matthew ; Hawi, Amale..
British Journal of Clinical Pharmacology. 89 (2023) 7 - p. 2088-2101 , 2023

Link: https://doi.org/10.1111/..

4

Usability of a novel digital medicine system in adults with..:

Peters-Strickland, Tim ; Pestreich, Linda ; Hatch, Ainslie...
Neuropsychiatric Disease and Treatment. 12 (2016) - p. 2587-2594 , 2016

Link: https://doi.org/10.2147/..

5

A pharmacometric case study regarding the sensitivity of st..:

Knights, Jonathan ; Rohatagi, Shashank
Journal of Pharmacokinetics and Pharmacodynamics. 42 (2015) 6 - p. 627-637 , 2015

Link: https://doi.org/10.1007/..

6

Development and application of an aggregate adherence metri..:

Knights, Jonathan ; Rohatagi, Shashank
Journal of Pharmacokinetics and Pharmacodynamics. 42 (2015) 3 - p. 263-273 , 2015

Link: https://doi.org/10.1007/..

7

Model‐Supported Development of CS‐8635: A Fixed‐Dose Combin..:

Song, SaeHeum ; Carrothers, Timothy J. ; Moore, Helen...
Clinical Pharmacology in Drug Development. 2 (2013) 2 - p. 103-112 , 2013

Link: https://doi.org/10.1002/..

8

Pharmacological Modulation of Peripheral T and B Lymphocyte..:

Moberly, James B. ; Rohatagi, Shashank ; Zahir, Hamim...
The Journal of Clinical Pharmacology. 52 (2012) 7 - p. 996-1006 , 2012

Link: https://doi.org/10.1177/..

9

Population Pharmacokinetic Model for a Novel Oral Hypoglyce..:

Kastrissios, Helen ; Walker, Joseph R. ; Carrothers, Timothy J....
The Journal of Clinical Pharmacology. 52 (2012) 3 - p. 404-415 , 2012

Link: https://doi.org/10.1177/..

10

Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patie..:

Wells, Thomas G. ; Blowey, Douglas L. ; Sullivan, Janice E....
Pediatric Drugs. 14 (2012) 6 - p. 401-409 , 2012

Link: https://doi.org/10.1007/..

11

Relationship Between Exposure to Prasugrel Active Metabolit..:

Riesmeyer, Jeffrey S. ; Salazar, Daniel E. ; Weerakkody, Govinda J....
The Journal of Clinical Pharmacology. 52 (2012) 6 - p. 789-797 , 2012

Link: https://doi.org/10.1177/..

12

Pharmacokinetics of Olmesartan Medoxomil in Pediatric Patie..:

Wells, Thomas G. ; Blowey, Douglas L. ; Sullivan, Janice E....
Pediatric Drugs. 14 (2012) 6 - p. 401-409 , 2012

Link: https://doi.org/10.2165/..

13

Integrated Analysis of Pharmacokinetic Data Across Multiple..:

Small, David S. ; Li, Ying G. ; Ernest II, C. Steven...
The Journal of Clinical Pharmacology. 51 (2011) 3 - p. 321-332 , 2011

Link: https://doi.org/10.1177/..

14

Correlation of Inhibition of Platelet Aggregation With Card..:

Wada, Russ ; Rohatagi, Shashank ; Small, David..
The Journal of Clinical Pharmacology. 50 (2010) 8 - p. 904-913 , 2010

Link: https://doi.org/10.1177/..

15

Population Pharmacokinetic Analyses to Evaluate the Influen..:

Wrishko, Rebecca E. ; Ernest II, C. Steven ; Small, David S....
The Journal of Clinical Pharmacology. 49 (2009) 8 - p. 984-998 , 2009

Link: https://doi.org/10.1177/..